Israel’s latest procedural step puts four Canadian producers in focus, while the distinction between an investigation and an imposed trade duty remains essential.
A small University of Auckland study will compare a cannabis oil with placebo over months, separating an important research question from claims of proven benefit.
The Canadian producer plans to expand output from existing facilities, with a lighting project bringing its combined capacity target forward to June 2027.
Minnesota’s next CanRenew round offers community restoration funding, with applications due December 15. The program does not finance cannabis business operations.
Aurora reports that Curaleaf’s application to halt its share-sale program was dismissed. Both companies continue to disagree over the proposed takeover’s value and process.
Calyx’s new packOS platform starts with label quoting. Its launch raises practical questions about artwork, production scope and the compliance work that remains with brands.
Holistic Solutions announces Monday–Wednesday delivery from its Atco dispensary starting October 26. Customers should verify their address and current terms before ordering.
Health Canada recalled one OVERTIME Punch Out dried-flower lot after THC and CBD values were switched on its label. Ontario purchasers should check the lot number.
710 Labs’ California calendar lists Close Friends releases beginning October 26 with a new packaging format. Retail availability and release times remain store-specific.
LOT420’s new GMP certificate covers specified medicinal flower operations in Quebec. Its detailed scope matters as Canadian producers pursue European medical markets.